Assistance Publique - Hôpitaux de Paris: Shock, Septic trials

The registry lists 21 Shock, Septic studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 10 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 6No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Value of Biomarkers of Brain Injury for Predicting Psycho-cognitive Sequelae Secondary to Sepsis: a Prospective Multicenter StudyNot yet recruitingNCT07746050Not applicable
• Alterations of the Renin-angiotensin-aldosterone System in sEptic ShockNot yet recruitingNCT07721974Not applicable
• Comparison of Manual PAOP and Automatic PAOP (Smart Wedge)Not yet recruitingNCT07703592
• Effect of Adding Vasopressin on Cardiac Output, Blood Pressure, Diuresis, and Tissue Perfusion Indices in Patients With Septic ShockNot yet recruitingNCT07697144
• Characterizing Perfusion and Congestion Responses to Fluid Loading in Critically Ill Septic PatientsNot yet recruitingNCT07685002
• Comparison of Cardiac Index Measurement Using Right Ventricular Pressure Curve Analysis and Thermodilution Via a Swan-Ganz IQ™ Catheter.Not yet recruitingNCT07628023
• Evaluation of Early Administration of Levetiracetam in the Prevention and Treatment Encephalopathy in Septic Shock: Randomized, Double-blind, Placebo-controlled TrialNot yet recruitingNCT06851078Phase 3
• Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2RecruitingNCT06062303Not applicable
• LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)RecruitingNCT04931225Phase 3
• Rate, Rhythm or Risk Control for New-onset Supraventricular Arrhythmia During Septic Shock: a Randomized Controlled TrialRecruitingNCT04844801Not applicable
• Metformine as a Protective Factor of Mortality in Type 2 Diabetic Patients Admitted to the ICU for Septic Shock.CompletedNCT07591402
• Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic ShockCompletedNCT05094856
• Modulation of Endothelial Dysfonction Using Vitamin C in Septic Shock PatientsStatus unknownNCT04778605
• Ivabradine for Heart Rate Control In Septic ShockCompletedNCT04031573Phase 3
• TRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic ShockCompletedNCT03837171Phase 3
• ILOPROST in Septic Shock With Persistent Microperfusion Defects (I-MICRO)CompletedNCT03788837Phase 3
• Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic ShockCompletedNCT02473263Phase 3
• Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic ShockActive, not recruitingNCT02120404Phase 2
• Septic cArdiac Deficiency and MenIngococcal seveRe SepsisCompletedNCT02041663Not applicable
• Personalized Mean Arterial Pressure Management on Renal Function During Septic ShockTerminatedNCT01473498Not applicable
• External Cooling in Septic Shock PatientsCompletedNCT00527007Not applicable